TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC

Pharmacy PHA

Funding for FDA offices; S.296. Preserving Access to Life-Saving Medications Act; women's issues relating to and implementation of the Affordable Care Act, including biologics; prescription drug abuse/diversion proposals; S.1357, Affordable Medicines Utilization Act of 2011; S.1882, Fair & Immediate Release of Generic Drugs Act; H.R.4332, Generic Drug Application Review Fairness Act; FDA Innovation & Safety Act; S.2295, Patient Safety & Generic Labeling Improvement Act; drug shortages; Drug Safety and Accountability Act (proposal from 111th Congress); S.330, Consumer Protection Recall Act of 2011; Medicaid pharmacy issues.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Contacted: Patent & Trademark Office (PTO); White House Office; Food & Drug Administration (FDA); SENATE; Drug Enforcement Administration (DEA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 296 (112th), S. 1357 (112th), S. 330 (112th), S. 2295 (112th), S. 1882 (112th), H.R. 4332 (112th)

Copyright/Patent/Trademark CPT

S.27, Preserve Access to Affordable Generics Act; and S.1882, Fair & Immediate Release of Generic Drug Act

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO)

Bills named: S. 27 (112th), S. 1882 (112th)

Trade (domestic/foreign) TRD

Trans-Pacific Partnership Trade Agreement

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc. has an indirect interest in the issues listed above.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Drug Enforcement Administration (DEA); U.S. Trade Representative (USTR); SENATE; Patent & Trademark Office (PTO)

Tariff (miscellaneous tariff bills) TAR

H.R.5698, legislation temporarily suspending the duty on S-(2-benzothiazolyl)-2-(2-amino-thiazol-4-yl)-2-acetoxyimino thiocetate (Thioester).

Foreign entity interest: Teva Pharmaceuticals, Ltd., as an indirect parent of Teva Pharmaceuticals USA, Inc., has an indirect interest in the issue(s) listed above.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; Patent & Trademark Office (PTO)

Bills named: H.R. 5698 (112th)